)
)
XVIVO Perfusion Investor Relations Material
Latest events
Q4 2024
XVIVO Perfusion
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from XVIVO Perfusion
Access all reports
Segment Data
Access more data
Net sales by
Business area
Thoracic
Abdominal
Services
Expenses by
Financials
Xvivo Perfusion AB, a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company's primary product line are the xVivo Perflex System and the xVivo S System that combine perfusion technology with a robust cryopreservation solution to maintain viability of cells outside the body. The xVivo Perflex System is used for functional organ preservation. The company is based in Gothenburg, Sweden.
Key slides for XVIVO Perfusion
Q2 2024
XVIVO Perfusion
Q4 2024
XVIVO Perfusion
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
XVIVO
Country
🇸🇪 Sweden